Gisslinger H - Search Results

1

Efficacy of cyclosporin A in systemic sclerosis.

Gisslinger H, Burghuber OC, Stacher G, Schwarz W, Punzengruber C, Graninger W, Luger TA, Wolff K, Smolen JS. Gisslinger H, et al. Clin Exp Rheumatol. 1991 Jul-Aug;9(4):383-90. Clin Exp Rheumatol. 1991. PMID: 1934687

2

Marked and sustained improvement of systemic sclerosis following polychemotherapy for coexistent multiple myeloma.

Bachleitner-Hofmann T, Machold K, Knobler R, Drach J, Grumbeck E, Gisslinger H. Bachleitner-Hofmann T, et al. Among authors: gisslinger h. Clin Exp Rheumatol. 2002 Jan-Feb;20(1):85-8. Clin Exp Rheumatol. 2002. PMID: 11892717

3

Treatment and prophylaxis of chemotherapy-induced gastrointestinal complaints.

Kotzmann H, Gisslinger H. Kotzmann H, et al. Among authors: gisslinger h. Scand J Gastroenterol Suppl. 1992;191:12-5. doi: 10.3109/00365529209093224. Scand J Gastroenterol Suppl. 1992. PMID: 1411291

4

Thyroid autoimmunity and hypothyroidism during long-term treatment with recombinant interferon-alpha.

Gisslinger H, Gilly B, Woloszczuk W, Mayr WR, Havelec L, Linkesch W, Weissel M. Gisslinger H, et al. Clin Exp Immunol. 1992 Dec;90(3):363-7. doi: 10.1111/j.1365-2249.1992.tb05852.x. Clin Exp Immunol. 1992. PMID: 1458673 Free PMC article.

5

Phase II study of amonafide in advanced breast cancer.

Scheithauer W, Dittrich C, Kornek G, Haider K, Linkesch W, Gisslinger H, Depisch D. Scheithauer W, et al. Among authors: gisslinger h. Breast Cancer Res Treat. 1991 Dec;20(1):63-7. doi: 10.1007/BF01833358. Breast Cancer Res Treat. 1991. PMID: 1813070 Clinical Trial.

6

Interferon in essential thrombocythaemia.

Gisslinger H, Chott A, Scheithauer W, Gilly B, Linkesch W, Ludwig H. Gisslinger H, et al. Br J Haematol. 1991 Oct;79 Suppl 1:42-7. doi: 10.1111/j.1365-2141.1991.tb08118.x. Br J Haematol. 1991. PMID: 1931708

7

Granulocyte colony-stimulating factor-supported combined immunosuppressive therapy (antilymphocyte globulin, cyclosporine, and methylprednisolone) in patients with aplastic anemia: tolerability, efficacy, and changes in the progenitor cell compartment.

Meidlinger P, Knöbl P, Jäger U, Gisslinger H, Pabinger I, Weltermann A, Lechner K, Geissler K. Meidlinger P, et al. Among authors: gisslinger h. Ann Hematol. 1999 Jul;78(7):299-304. doi: 10.1007/s002770050519. Ann Hematol. 1999. PMID: 10466441

8

Ineffectiveness of interferon-gamma in the treatment of idiopathic myelofibrosis: a pilot study.

Heis-Vahidi-Fard N, Forberg E, Eichinger S, Chott A, Lechner K, Gisslinger H. Heis-Vahidi-Fard N, et al. Among authors: gisslinger h. Ann Hematol. 2001 Feb;80(2):79-82. doi: 10.1007/s002770000231. Ann Hematol. 2001. PMID: 11261329

9

Long-term alpha-interferon therapy in myelodysplastic syndromes.

Gisslinger H, Chott A, Linkesch W, Fritz E, Ludwig H. Gisslinger H, et al. Leukemia. 1990 Feb;4(2):91-4. Leukemia. 1990. PMID: 2106057

10

Erythropoietin treatment of anemia associated with multiple myeloma.

Ludwig H, Fritz E, Kotzmann H, Höcker P, Gisslinger H, Barnas U. Ludwig H, et al. Among authors: gisslinger h. N Engl J Med. 1990 Jun 14;322(24):1693-9. doi: 10.1056/NEJM199006143222402. N Engl J Med. 1990. PMID: 2342535 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

266 results

Search Page

Filters